Jay Shepard - 21 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Reporting relationship: Director
Issuer ticker: INO
Reported as of: 21 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2025, 16:58:15 UTC
Prior SEC filing: 21 Jun 2024
Next SEC filing: 02 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Jay P. Shepard

Key filing fact

Jay Shepard filed Form 4 for INOVIO PHARMACEUTICALS, INC. (INO) on 21 May 2025.

Key facts

This page summarizes Jay Shepard's Form 4 filing for INOVIO PHARMACEUTICALS, INC. (INO).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2025, 16:58.

Change

Previous filing in this sequence was filed on 21 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001587788 Primary reporting owner

Shepard Jay

Relationship: Director
Address: 660 W. GERMANTOWN PIKE SUITE 110, PLYMOUTH MEETING
Signature: /s/ Jay P. Shepard
Signature date: 21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INO transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,167
Change %: +31%
Price
Shares after: 9,209
Date: 21 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INO transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -2,167
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 21 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,167
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025.